AndreaKellyMD
Pediatric Endocrinology • Philadelphia, PAAssistant Professor, Pediatrics, Perelman School of Medicine
Are you Dr. Kelly?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3401 Civic Center Blvd
Children's Hospital Of Philadelphia - Endocrinology
Philadelphia, PA 19104Phone+1 215-590-3174Fax+1 215-590-3053
Summary
- Dr. Andrea Kelly, MD is a pediatric endocrinologist in Philadelphia, Pennsylvania. She is currently licensed to practice medicine in Pennsylvania. She is an Assistant Professor at Perelman School of Medicine.
Education & Training
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1995
Certifications & Licensure
PA State Medical License 1996 - 2026- PA State Medical License 1997 - 2026
American Board of Pediatrics Pediatric Endocrinology
Publications & Presentations
PubMed
- A comparison of ultrasound-based testis volume with Prader orchidometry and stability of testis size relative to peers from birth to 28 weeks.Helen B Chin, Thomas H Amabile, Andrea Kelly, Stacy A Patchel, Kassa Darge
Andrology. 2025-02-01 - Bone Health and Linear Growth in Children with Familial Hypoparathyroidism Treated with Human Parathyroid Hormone 1-34.Karen K Winer, Babette S Zemel, Andrea Kelly, James C Reynolds, Joseph Pechacek
The Journal of Clinical Endocrinology and Metabolism. 2025-01-30 - Antibiotic exposure is associated with minimal gut microbiome perturbations in healthy term infants.Alain J Benitez, Ceylan Tanes, Elliot S Friedman, Joseph P Zackular, Eileen Ford
Microbiome. 2025-01-24
Press Mentions
- Hormone Infusion Improves Pancreatic Insulin Production in Cystic Fibrosis Patients with or at Risk for Diabetes, Penn Study FindsJuly 21st, 2022
- Business Summary | Business | Herald Dispatch.comJuly 18th, 2021
- Istari Oncology Presents Positive Data from Phase 1 Study of PVSRIPO in Patients with Unresectable Treatment Refractory Melanoma at the Society for Immunotherapy of Cancer (SITC) 35th Anniversary Annual MeetingNovember 9th, 2020
